Spring Pharmaceutical Group Top Insiders
Spring Pharmaceutical employs about 279 people. The company is managed by 12 executives with a total tenure of roughly 160 years, averaging almost 13.0 years of service per executive, having 23.25 employees per reported executive. Examination of Spring Pharmaceutical's management performance can provide insight into the company performance.
| Tinghe Yan Chairman Chairman and CEO |
Spring |
Spring Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 12.27 % which means that it generated a profit of $12.27 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 14.93 %, meaning that it created $14.93 on every $100 dollars invested by stockholders. Spring Pharmaceutical's management efficiency ratios could be used to measure how well Spring Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Spring Pharmaceutical Workforce Comparison
Spring Pharmaceutical Group is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 378,794. Spring Pharmaceutical adds roughly 279 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 20.41 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 28.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $28.11. Spring Pharmaceutical Notable Stakeholders
A Spring Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spring Pharmaceutical often face trade-offs trying to please all of them. Spring Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spring Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tinghe Yan | Chairman and CEO | Profile | |
| Chuanming Li | CFO | Profile | |
| Dong Li | Director | Profile | |
| Wengao Zhang | Independent Director | Profile | |
| Robert Fanella | Independent Director | Profile | |
| John Wallace | Independent Director | Profile | |
| Jirui Zhang | Director | Profile | |
| Zecheng Shao | VP | Profile | |
| Qiang Zhang | Chief Admin. Officer | Profile | |
| Hanwei Zhou | General Manager of Shandong Spring Pharmaceutical | Profile | |
| Xuzhong Ding | Chief Marketing Officer | Profile | |
| Sun Maogang | General Manager of Shandong Spring Pharmaceutical | Profile |
Spring Pharmaceutical Workforce Analysis
Traditionally, organizations such as Spring Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spring Pharmaceutical within its industry.Spring Pharmaceutical Manpower Efficiency
Return on Spring Pharmaceutical Manpower
| Revenue Per Employee | 271.7K | |
| Revenue Per Executive | 6.3M | |
| Net Income Per Employee | 55.4K | |
| Net Income Per Executive | 1.3M | |
| Working Capital Per Employee | 41.1K | |
| Working Capital Per Executive | 954.5K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Spring Pink Sheet
If you are still planning to invest in Spring Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spring Pharmaceutical's history and understand the potential risks before investing.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |